Found: 12
Select item for more details and to access through your institution.
Nasopharyngeal Viral Load Is the Major Driver of Incident Antibody Immune Response to SARS-CoV-2 Infection.
- Published in:
- Open Forum Infectious Diseases, 2023, v. 10, n. 12, p. 1, doi. 10.1093/ofid/ofad598
- By:
- Publication type:
- Article
Inhibition of prostacyclin and thromboxane biosynthesis in healthy volunteers by single and multiple doses of acetaminophen and indomethacin.
- Published in:
- Clinical Pharmacology in Drug Development, 2015, v. 4, n. 5, p. 337, doi. 10.1002/cpdd.194
- By:
- Publication type:
- Article
Virologic Efficacy of Casirivimab and Imdevimab COVID-19 Antibody Combination in Outpatients With SARS-CoV-2 Infection: A Phase 2 Dose-Ranging Randomized Clinical Trial.
- Published in:
- JAMA Network Open, 2022, v. 5, n. 8, p. e2225411, doi. 10.1001/jamanetworkopen.2022.25411
- By:
- Publication type:
- Article
Virologic Efficacy of Casirivimab and Imdevimab COVID-19 Antibody Combination in Outpatients With SARS-CoV-2 Infection: A Phase 2 Dose-Ranging Randomized Clinical Trial.
- Published in:
- JAMA Network Open, 2022, v. 5, n. 8, p. 1, doi. 10.1001/jamanetworkopen.2022.25411
- By:
- Publication type:
- Article
Evaluation of the pharmacokinetics of digoxin in healthy subjects receiving etoricoxib.
- Published in:
- British Journal of Clinical Pharmacology, 2008, v. 66, n. 6, p. 811, doi. 10.1111/j.1365-2125.2008.03285.x
- By:
- Publication type:
- Article
Comment on Jaki et al., A proposal for a new PhD level curriculum on quantitative methods for drug development. Pharmaceutical Statistics 17 (5):593–606, Sep/Oct 2018, DOI: 10.1002/pst.1873.
- Published in:
- Pharmaceutical Statistics, 2019, v. 18, n. 3, p. 278, doi. 10.1002/pst.1940
- By:
- Publication type:
- Article
Efficacy and Safety of Sarilumab in Hospitalized Patients With Coronavirus Disease 2019: A Randomized Clinical Trial.
- Published in:
- Clinical Infectious Diseases, 2022, v. 75, n. 1, p. e380, doi. 10.1093/cid/ciac153
- By:
- Publication type:
- Article
Effect of Subcutaneous Casirivimab and Imdevimab Antibody Combination vs Placebo on Development of Symptomatic COVID-19 in Early Asymptomatic SARS-CoV-2 Infection: A Randomized Clinical Trial.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Single- and Multiple-Dose Pharmacokinetics of Etoricoxib, a Selective Inhibitor of Cyclooxygenase-2, in Man.
- Published in:
- Journal of Clinical Pharmacology, 2003, v. 43, n. 3, p. 268, doi. 10.1177/0091270003251122
- By:
- Publication type:
- Article
Safety and tolerability of sitagliptin in clinical studies: a pooled analysis of data from 10,246 patients with type 2 diabetes.
- Published in:
- BMC Endocrine Disorders, 2010, v. 10, p. 7, doi. 10.1186/1472-6823-10-7
- By:
- Publication type:
- Article
Human Monoclonal Antibody Cocktail for the Treatment or Prophylaxis of Middle East Respiratory Syndrome Coronavirus.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Casirivimab + imdevimab accelerates symptom resolution linked to improved COVID-19 outcomes across susceptible antibody and risk profiles.
- Published in:
- Scientific Reports, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41598-023-39681-7
- By:
- Publication type:
- Article